81 related articles for article (PubMed ID: 25535748)
1. Glucocerebrosidase gene mutations associated with Parkinson's disease: a meta-analysis in a Chinese population.
Chen J; Li W; Zhang T; Wang YJ; Jiang XJ; Xu ZQ
PLoS One; 2014; 9(12):e115747. PubMed ID: 25535748
[TBL] [Abstract][Full Text] [Related]
2. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
Robak LA; Jansen IE; van Rooij J; Uitterlinden AG; Kraaij R; Jankovic J; ; Heutink P; Shulman JM
Brain; 2017 Dec; 140(12):3191-3203. PubMed ID: 29140481
[TBL] [Abstract][Full Text] [Related]
3. Glucocerebrosidase and Parkinson disease: Recent advances.
Schapira AH
Mol Cell Neurosci; 2015 May; 66(Pt A):37-42. PubMed ID: 25802027
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity among patients with Parkinson's disease: cluster analysis and genetic association.
Ma LY; Chan P; Gu ZQ; Li FF; Feng T
J Neurol Sci; 2015 Apr; 351(1-2):41-45. PubMed ID: 25732803
[TBL] [Abstract][Full Text] [Related]
5. GBA mutations and Parkinson disease: when genotype meets phenotype.
Scholz SW; Jeon BS
Neurology; 2015 Mar; 84(9):866-7. PubMed ID: 25653294
[No Abstract] [Full Text] [Related]
6. Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation.
Yang C; Wang H; Zhu D; Hong CS; Dmitriev P; Zhang C; Li Y; Ikejiri B; Brady RO; Zhuang Z
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1137-42. PubMed ID: 25583479
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of severe vs mild GBA mutations on Parkinson disease.
Gan-Or Z; Amshalom I; Kilarski LL; Bar-Shira A; Gana-Weisz M; Mirelman A; Marder K; Bressman S; Giladi N; Orr-Urtreger A
Neurology; 2015 Mar; 84(9):880-7. PubMed ID: 25653295
[TBL] [Abstract][Full Text] [Related]
8. Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease.
Spitz M; Pereira JS; Nicareta DH; Abreu Gde M; Bastos EF; Seixas TL; Pimentel MM
Parkinsonism Relat Disord; 2015 Jul; 21(7):825-6. PubMed ID: 25952961
[No Abstract] [Full Text] [Related]
9. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
[TBL] [Abstract][Full Text] [Related]
11. Presenting symptoms of GBA-related Parkinson's disease.
Kresojević N; Janković M; Petrović I; Kumar KR; Dragašević N; Dobričić V; Novaković I; Svetel M; Klein C; Pekmezović T; Kostić VS
Parkinsonism Relat Disord; 2015 Jul; 21(7):804-7. PubMed ID: 25957717
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.
Dahl M; Doyle A; Olsson K; Månsson JE; Marques ARA; Mirzaian M; Aerts JM; Ehinger M; Rothe M; Modlich U; Schambach A; Karlsson S
Mol Ther; 2015 May; 23(5):835-844. PubMed ID: 25655314
[TBL] [Abstract][Full Text] [Related]
13. [Genetic factors associated with dementia in Parkinson's disease (PD)].
Romo-Gutiérrez D; Yescas P; López-López M; Boll MC
Gac Med Mex; 2015; 151(1):110-8. PubMed ID: 25739491
[TBL] [Abstract][Full Text] [Related]
14. The association between lysosomal protein glucocerebrosidase and Parkinson's disease.
Eur Rev Med Pharmacol Sci; 2015; 19(2):179. PubMed ID: 25683925
[No Abstract] [Full Text] [Related]
15. Dissociation of glucocerebrosidase dimer in solution by its co-factor, saposin C.
Gruschus JM; Jiang Z; Yap TL; Hill SA; Grishaev A; Piszczek G; Sidransky E; Lee JC
Biochem Biophys Res Commun; 2015 Feb; 457(4):561-6. PubMed ID: 25600808
[TBL] [Abstract][Full Text] [Related]
16. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.
Siebert M; Westbroek W; Chen YC; Moaven N; Li Y; Velayati A; Saraiva-Pereira ML; Martin SE; Sidransky E
RNA Biol; 2014; 11(10):1291-300. PubMed ID: 25584808
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-quenched substrates for live cell imaging of human glucocerebrosidase activity.
Yadav AK; Shen DL; Shan X; He X; Kermode AR; Vocadlo DJ
J Am Chem Soc; 2015 Jan; 137(3):1181-9. PubMed ID: 25562638
[TBL] [Abstract][Full Text] [Related]
18. Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.
Leyns CEG; Prigent A; Beezhold B; Yao L; Hatcher NG; Tao P; Kang J; Suh E; Van Deerlin VM; Trojanowski JQ; Lee VMY; Kennedy ME; Fell MJ; Henderson MX
NPJ Parkinsons Dis; 2023 May; 9(1):74. PubMed ID: 37169750
[TBL] [Abstract][Full Text] [Related]
19. Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Yahya V; Di Fonzo A; Monfrini E
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047309
[TBL] [Abstract][Full Text] [Related]
20. Glucocerebrosidase mutations and Parkinson disease.
Vieira SRL; Schapira AHV
J Neural Transm (Vienna); 2022 Sep; 129(9):1105-1117. PubMed ID: 35932311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
